ATRA vs CDNS · rev $128.9M vs P/E 82, rev $5.30B
Atara Biotherapeutics Inc (ATRA) versus Cadence Design Systems Inc (CDNS) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Cadence Design Systems Inc (CDNS) is a software - application company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported CDNS revenue for 2025-12-31 was $5.30B. Net income was $1.11B. Revenue was up 14.1% from 2024-12-31 to 2025-12-31. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
ATRA currently screens at market cap $87.1M. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
Not investment advice. Open the ATRA and CDNS stock pages for the full models.
Not investment advice.